Search Results

Showing results 111 - 120 for weill cornell connect patient portal

Monoclonal Antibody for Desmin (D76) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-desmin-d76

Monoclonal Antibody for Muscle Fast C-Protein (MF1) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-muscle-fast-c-protein-mf1

Monoclonal Antibody for Myosin Heavy Chain (MF20) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-myosin-heavy-chain-mf20

Monoclonal Antibody for Neonatal and Adult Myosin Heavy Chain (MF30) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-neonatal-and-adult-myosin-heavy

Monoclonal Antibody for Myosin Fast Muscle Light Chain 2 (MF5) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/monoclonal-antibody-myosin-fast-muscle-light-chain

Antibody for Immunopurification of Peptides Derived from Ubiquitinated Proteins (GX41) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/antibody-immunopurification-peptides-derived

Anti-sAC Monoclonal Antibody (R5) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/anti-sac-monoclonal-antibody-r5

Anti-sAC Monoclonal Antibody (R21) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/anti-sac-monoclonal-antibody-r21

Anti-sAC Monoclonal Antibody (R37) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/anti-sac-monoclonal-antibody-r37

Anti-sAC Monoclonal Antibody (R41) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/anti-sac-monoclonal-antibody-r41

Showing results 111 - 120 for weill cornell connect patient portal